What this study adds:
- The safety profile of HCQ changed when used in Covid-19 patients.
- Hepatic, cardiovascular, and gastrointestinal ADR were more frequents
in Covid-19 patients while skin, eye and nervous system disorders were
more frequents in noCovid-19 patients.
- Some signals identified need to be confirmed.